CARDAX, INC. (OTCMKTS:CDXI) Files An 8-K Submission of Matters to a Vote of Security Holders

CARDAX, INC. (OTCMKTS:CDXI) Files An 8-K Submission of Matters to a Vote of Security Holders

Story continues below

About CARDAX, INC. (OTCMKTS:CDXI)

Cardax, Inc. is a life sciences company. The Company develops consumer health and pharmaceutical technologies. The Company is engaged in developing and commercializing anti-inflammatory dietary supplements and drugs. The Company offers ZanthoSyn, a product to help consumers address their inflammatory health. ZanthoSyn is an astaxanthin dietary supplement distributed by the Company. ZanthoSyn features synthetic astaxanthin. Astaxanthin is an ingredient with anti-inflammatory activity that supports joint health, cardiovascular health, metabolic health and liver health. As of December 31, 2015, the Company had two other anti-inflammatory programs with application in various markets, including zeaxanthin esters for macular degeneration and hepatic disease, and lycophyll esters for prostate disease.

An ad to help with our costs